πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7604944

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601690

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592355

Quinolinone-carboxamide compounds as 5-HT, receptor agonists

Theravance, Inc. Β· Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585879

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585653

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, n

Theravance, Inc. Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582765

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572918

Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compound

Theravance, Inc. Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569588

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569586

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566785

Amidine substituted aryl aniline compounds

Theravance, Inc. Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560469

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557247

Crystalline form of Ξ²2 adrenergic receptor agonist

Theravance, Inc. Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7557126

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553971

Aryl aniline Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553962

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550595

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544364

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

Theravance, Inc. Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534889

5-HT4 receptor agonist compounds

Theravance, Inc. Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531623

Hydrochloride salts of a glycopeptide phosphonate derivative

Theravance, Inc. Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528253

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524965

Dialkylphenyl compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor anta

Theravance, Inc. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524962

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524959

Biphenyl derivatives

Theravance, Inc. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524880

Crystalline form of a substituted pyrrolidine compound

Theravance, Inc. Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted